R. Nuccorini

Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)

A. Amendola, G. Luzi, G. Paternoster, 2021, General Reanimatology.

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients

G. Martinelli, A. Amendola, A. Matturro, 2022, Frontiers in Immunology.

Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.

V. Pavone, A. Ostuni, G. Milone, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of some ATP-binding cassette transporters in acute myeloid leukemia

A. Ostuni, I. Attolico, F. Bisaccia, 2017, Hematology reports.

A refined composite clinical score for the early identification of the predicted Poor Mobilizers (PM): a GITMO analysis.

E. Nardo, F. Merli, F. Lanza, 2015 .

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

S. Svegliati, A. Gabrielli, F. Pane, 2013, Blood.

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)

A. Nagler, F. Ciceri, A. Bacigalupo, 2020, Bone Marrow Transplantation.

patients receiving imatinib for steroid-refractory chronic GVHD Long-term outcome and prospective validation of NIH response criteria

S. Svegliati, A. Gabrielli, F. Pane, 2013 .

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

G. Gaidano, F. Merli, F. Lanza, 2018, Bone Marrow Transplantation.

TRANSPLANTATION Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

S. Svegliati, A. Bacigalupo, F. Patriarca, 2013 .